Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population

Thrombosis and Haemostasis

Volumn 93, Issue 6, 2005, Pages 1095-1100

  Rubattu, Speranza ^a,b   Di Angelantonio, Emanuele ^b   Nitsch, Dorothea ^c   Gigante, Bruna ^d   Zanda, Bastianina ^e   Stanzione, Rosita ^a   Evangelista, Anna ^a   Pirisi, Angelo ^e   Rosati, Giulio ^e   Volpe, Massimo ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

Coagulation factors; Genetics; Polymorphisms; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTHROMBIN; THREONINE;

AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; HAPLOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; BLOOD COAGULATION FACTORS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FACTOR VII; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 20444507569     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-07-0457     Document Type: Article

References (39)

1. Rubattu S, Giliberti R, Volpe M. Etiology and pathophysiology of stroke as a complex phenotypic trait. Am J Hypertens 2000; 13: 1239-48.
2. Rubattu S, Volpe M, Kreutz R et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of human disease. Nature Genetics 1996; 13: 429-33.
3. Jeffs B, Clark J, Anderson N et al. Sensitivity to cerebral ischemic insult in a rat model of stroke is determined by a single genetic locus. Nature Genetics 1997; 16: 364-7.
4. Hassan A, Markus H. Genetics and ischemic stroke. Brain 2000; 123: 1784-812.
5. Rubattu S, Ridker P, Stampfer MJ et al. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999; 100: 1722-6.
6. Rubattu S, Stanzione R, Di Angelantonio E et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004; 35: 814-8.
7. Smith FB, Lee AJ, Fowkes FG et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscl Thromb Vasc Biol 1997; 17: 3321-5.
8. Ridker PM, Hennekens CH, Lindpaintner K et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7.
9. Poort SR, Rosendaal FR, Reitsman PH et al. A common genetic variation in the 3′-untraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
10. Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscl Thromb Vasc Biol 2004; 24: 1-14.
11. Endler G, Funk M, Haering D et al. Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 2003; 120: 310-4.
12. Corral J, Iniesta J, Gonzalez-Conejero R et al. Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 2001; 97: 2979-82.
13. Heywood D, Carter A, Catto A et al. Polymorphisms of the Factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997; 28: 816-21.
14. Nishiuma S, Kario K, Nakanishi K et al. Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls. Blood coagulation and fibrinolysis 1997; 8: 525-30.
15. Kario K, Matsuo M, Miyata T. Are there any associations among coagulation factor VII gene polymorphisms, plasma activated factor VII levels, and cerebrovascular disease? Circulation 2000; 101: E48.
16. Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes, pp 272-276 (Princeton University Press, Princeton 1994).
17. Siniscalco M, Robledo I, Bender PK et al. Population genomics in Sardinia: a novel approach to hunt for genomic combinations underlying complex traits and diseases. Cytogenet. Cell Genet 1999; 86: 148-52.
18. Lampis R, Morelli L, Congia M et al. The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 2000; 9: 2959-65.
19. Rubattu S, Di Angelantonio E, Stanzione R et al. Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens 2004; 22: 2129-34.
20. Marchetti G, Patracchini P, Gemmati D et al. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum Genetic 1992; 89: 497-502.
21. Dell'Acqua G, Iacoviello L, D'Orazio A et al. A polymorphic cluster in the 5′ region of the human coagulation Factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res 1997; 88: 445-8.
22. Bertina RM, Koeleman BPC, Loster T et al. Mutation in blood coagulation Factor V is associated with resistance to activated protein C. Nature 1994; 369: 64-79.
23. Carter AM, Catto AJ, Grant PJ. Association of the α-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation 1999; 99: 2323-426.
24. Blake GJ, Schmitz C, Lindpaintner K et al. Mutation in the promoter of the b-fibrinogen gene and the risk of future myocardial infarction, stroke, and venous thrombosis. Eur Heart J 2001; 22: 2262-6.
25. Mikkola H, Syrjala M, Rasi V et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-25.
26. Ridker PM, Hennekens CH, Schmitz C et al. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet 1997; 349: 385-8.
27. Falconer D. Introduction to quantitative genetics: Longman Scientific&Technical UK, 1994.
28. Mickey R, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-37.
29. SNPHAP: A Program for Estimating Frequencies of Large Haplotypes of SNPs, http://www-gene.cimr.cam.ac.uk/clayton/software/snphap.txt
30. Di Castelnuovo A, D'Orazio A, Amore C et al. Genetic modulation of coagulation Factor VII plasma levels: contribution of different polymorphisms and gender-related effects. Thromb Hemost 1998; 80: 592-7.
31. Bernardi F, Marchetti G, Pinotti M et al. Factor VII gene polymorphisms contribute about one third of the Factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-6.
32. Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clinica Chimica Acta 2003; 330: 31-55.
33. Wu A, Tsongalis G. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001; 87: 1361-6.
34. Shifman S, Darvasi A. The value of isolated populations. Nature Genetics 2001; 28: 309-10.
35. Elbaz A, Poirier O, Canaple S et al. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
36. Reiner A, Frank MB, Schwartz SM et al. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 2002; 116: 376-82.
37. Ariens RS, Lai T-S, Weisel JW et al. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100: 743-54.
38. Ridker CM, Hennekens CH, Schmitz C et al. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-8.
39. Blake GJ, Schmitz C, Lindpaintner K et al. Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001; 22: 2262-6.